# Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker

> **NCT04003220** · — · UNKNOWN · sponsor: **University Hospital, Bordeaux** · enrollment: 80 (estimated)

## Conditions studied

- Thrombocytopenia
- Purpura, Thrombocytopenic
- Myelodysplastic Syndromes

## Interventions

- **PROCEDURE:** blood sample
- **PROCEDURE:** Bone marrow sample

## Key facts

- **NCT ID:** NCT04003220
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-07
- **Primary completion:** 2023-09-07
- **Final completion:** 2023-09-07
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04003220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04003220, "Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04003220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*